Results 221 to 230 of about 17,246 (287)

Rituximab-Induced Esophageal Ulcers and Strictures Presenting as Dysphagia. [PDF]

open access: yesACG Case Rep J
Abdulrazzak MA   +4 more
europepmc   +1 more source

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Limited data are available on the management and outcomes of postoperative Crohn's disease (CD) in older patients. We aimed to describe the management of CD in the postoperative setting and assess surgical postoperative recurrence (POR) in this population.
Míriam Mañosa   +76 more
wiley   +1 more source

Endo-hepatology: Bridging the gap between lumen and liver. [PDF]

open access: yesWorld J Gastroenterol
Abdelhamed W, El-Kassas M.
europepmc   +1 more source

Changing the Flow: How EUS‐Guided Drainage is Reshaping the Management of Distal Malignant Biliary Obstruction

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Endoscopic ultrasound‐guided biliary drainage (EUS‐BD) has evolved from a rescue therapy into a viable alternative to endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous drainage for distal malignant biliary obstruction (dMBO).
Jeska A. Fritzsche   +4 more
wiley   +1 more source

An esophageal stent placement in a narrow distal esophagus stricture: A case report. [PDF]

open access: yesRadiol Case Rep
Eppy Buchori AK   +6 more
europepmc   +1 more source

Probe-based confocal laser endomicroscopy: progress, challenges, and emerging applications. [PDF]

open access: yesSurg Endosc
Ayyad M   +6 more
europepmc   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa   +2 more
wiley   +1 more source

Avascular Necrosis and Minimal Trauma Fractures in Telomere Biology Disorders

open access: yesClinical Genetics, Volume 109, Issue 2, Page 286-293, February 2026.
Avascular Necrosis (AVN) and Minimal Trauma Fractures (MTF) cause significant morbidity in people with Telomere Biology Disorders (TBDs). They occur more frequently in young patients and in those with autosomal recessive (AR) or X‐linked recessive (XLR) than in autosomal dominant (AD) genotypes.
Arman M. Niknafs   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy